INNOCELL TECHNOLOGY CO., LTD.
Update：2026/11/10
Industries
Main Industry
Biotechnology
Main Product/Service
Immune Cell Processing and Exosome Purification Platform Technologies (iKNOBeads, iGDP, iCDV)
The content above was translated by Ai
Founded Year
2024
Unified Business No.
95434189
Status
Active
Number of Employees
0
Total capital
200,000 (NT$)
Location of Company
Taiwan
, Taipei City
Website
Company names, registration status, legal representatives, founding years, paid-in capital, registered addresses, and other details are sourced from business registration records maintained by Taiwan’s Administration of Commerce, Ministry of Economic Affairs. Exit status includes Emerging Stock Board listings, M&A, and IPOs. Information on overseas expansion is self-reported by startups.
Note 1: FINDIT compiles company information from public and other sources for reference and does not serve as a point of contact for the companies listed.
Note 2: Some company profiles and product/service descriptions are translated using AI and provided for reference only. In case of discrepancies or ambiguity, the original text prevails.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
INNOCELL TECHNOLOGY is a spin-off startup from the Industrial Technology Research Institute (ITRI) that focuses on the development of key materials for immune cell processing and exosome processing platform technologies. The company’s core technologies include the biomimetic magnetic bead-based immune cell production platform (iKNOBeads), the non-viral nuclear delivery platform (iGDP), and the high-purity exosome production platform (iCDV). These technologies can be applied to the activation and expansion of immune cells, cell engineering, and exosome production development, helping to enhance the efficiency, stability, and scalability of cell and exosome production processes.
The content above was translated by Ai
